TransCode Therapeutics Inc Sustainability Reports
TransCode Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing RNA-based therapeutics and diagnostics for the treatment and detection of advanced and high-risk cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2024 to 2024
Company Profile
TransCode Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing RNA-based therapeutics and diagnostics for the treatment and detection of advanced and high-risk cancers.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years